Results 151 to 160 of about 14,945 (175)

The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials. [PDF]

Cancer Res Commun
Solomon BJ, Tan DSW, de Castro G, Cobo M, Garassino MC, Zhang J, Johnson BE, Lee JM, Garrido P, Butler AA, Pelletier MR, Savchenko A, Ji L, Brase JC, Caparica R, Demanse D, Wu J, Bossen C, Mok T.   +18 more
europepmc   +1 more source

Targeting Atherosclerosis: Cholesterol-Lowering Therapies with a New Immunometabolic Dress for an Old Disease. [PDF]

J Clin Med
Julve J, Rodriguez-Calvo R, Perret B, Martinez LO, Mauricio D.   +4 more
europepmc   +1 more source

Pyoderma Gangrenosum with Biological Agents Therapy: A Systematic Review. [PDF]

Clin Cosmet Investig Dermatol
Tan B, Chen M, Hu X, He J, Zhang L, Du S, Mou Y, Xiong X, Duan X.   +8 more
europepmc   +1 more source

Canakinumab Treatment in Familial Mediterranean Fever Patients: With/Without Colchicine. [PDF]

Int J Rheum Dis
Öğüt TS, Yazisiz V, Dilbil M, Nokay M, Terzioğlu ME, Erbasan F.   +5 more
europepmc   +1 more source

Atherosclerosis and Inflammation: Are the Rules of the Game Changing with Biological Therapies? [PDF]

J Inflamm Res
Bora R, Kılıç AT, Toprak B.
europepmc   +1 more source

Inhibition of interleukin-1 or -6 after myocardial infarction: pros, cons, and future perspectives. [PDF]

Eur Heart J Cardiovasc Pharmacother
Galli M, Gurgoglione FL, Sciarretta S, Abbate A.   +3 more
europepmc   +1 more source

Gout therapy updated. [PDF]

Ther Adv Musculoskelet Dis
McCarty KL, Gaffo AL, Diaz-Torne C.
europepmc   +1 more source

Efficacy and safety of anti-interleukin-6 treatment in familial Mediterranean fever: a systematic literature review. [PDF]

Reumatologia
Saidane O, Bouden S, Jerbi A, Rouached L, Mahmoud I, Tekaya R, Tekaya AB, Abdelmoula L.   +7 more
europepmc   +1 more source

Beyond Lipids and Platelets: A Review of Anti-Inflammatory Strategies in Secondary Prevention of Acute Coronary Syndromes. [PDF]

J Clin Med
Pathangey G, Allam MN, Abdelnabi MH, Sorajja D, Fortuin FD, Lee KS, Bhakta MD.   +6 more
europepmc   +1 more source